Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bodhi Tree Biotechnology (BDTB) Net Margin (2024 - 2025)

Historic Net Margin for Bodhi Tree Biotechnology (BDTB) over the last 2 years, with Q3 2025 value amounting to 89.06%.

  • Bodhi Tree Biotechnology's Net Margin changed N/A to 89.06% in Q3 2025 from the same period last year, while for Dec 2025 it was 1148.64%, marking a year-over-year change of. This contributed to the annual value of 880.39% for FY2025, which is N/A changed from last year.
  • Latest data reveals that Bodhi Tree Biotechnology reported Net Margin of 89.06% as of Q3 2025.
  • Bodhi Tree Biotechnology's 5-year Net Margin high stood at 89.06% for Q3 2025, and its period low was 1295.54% during Q4 2024.